Editas Medicine rises on narrower Q4 loss

Editas Medicine

28/02/2024 18:21

** Shares of drug developer Editas Medicine  EDIT.O  rise as
much as 30.7% to over 2-month high of $11.58
    ** Stock set for its biggest one-day pct. rise in over 3
years if gains hold
    ** Co posts a narrower Q4 loss of 0.23/shr vs 0.88/shr a
year ago
    ** EDIT reports collaboration and other R&D revenue of $60
mln compared with $6.5 mln a year ago
    ** Co's cash, cash equivalents and marketable securities as
of Dec. 31 were $427.10 mln
    ** Stock up 22.1% in the last 12 months

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))